Hepatic Arterial Therapy with Drug-Eluting Beads in the Management of Metastatic Bronchogenic Carcinoma to the Liver: A Multi-Institutional Registry

Table 2

Bead catheter infusion outcomes.

	𝑁=30 total treatments
Number of bead courses	Median 2 (range 1–5)
Technical success	97%
Dosage delivered (median, range)	75 mg (19–200)
Total hepatic dose exposure	150 (0–458)
1	150 (0–200)
2	150 (79–190)
3	325
>3	458
Bead Size Utilized
100–300	24
300–500	5
500–700	1
Complications	14%
Extrahepatic infusion	0
Hematologic changes
WBC	−1.9 (−9994.4–9991.8)
HGB	0.1 (−9989.1–9987.5)
Bilirubin	0 (−9998.7–9998.8)